ICU Medical Expects FY24 Adjusted EPS Of $4.40-$5.10, Est $5.18
Portfolio Pulse from Benzinga Newsdesk
ICU Medical forecasts its FY24 adjusted EPS to be between $4.40 and $5.10, which is below the estimated $5.18. The company anticipates a GAAP net loss of $88 to $71 million and a diluted loss per share of $3.57 to $2.87. Adjusted EBITDA is expected to range from $330 million to $370 million.
February 27, 2024 | 10:20 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ICU Medical forecasts a lower-than-expected adjusted EPS for FY24 and anticipates a GAAP net loss, with adjusted EBITDA between $330 million and $370 million.
The company's forecast of a lower-than-expected adjusted EPS for FY24 and the anticipation of a GAAP net loss could negatively impact investor sentiment and the stock price in the short term. The adjusted EBITDA range, while providing some positive outlook, may not be sufficient to offset the negative earnings projection.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100